Revolution Medicines (RVMD) EPS (Basic) (2019 - 2026)
Revolution Medicines' (RVMD) quarterly EPS (Basic) came in at -$2.29 in Q1 2026, down 101.96% year-on-year from $116.82 in Q1 2025, and down 19.37% quarter-over-quarter from -$1.92 in Q4 2025.
Revolution Medicines (RVMD) EPS (Basic) (2019 - 2026) Analysis & Trends
Revolution Medicines' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$2.29 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 101.96% year-over-year to -$2.29 in Q1 2026; TTM through Mar 2026 was -$6.92, a 86.78% decrease from a year earlier, with the FY2025 full-year figure at -$5.95, down 66.32% from the prior year.
- EPS (Basic) declined to -$2.29 in Q1 2026 per RVMD's latest filing, from -$1.92 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.7 in Q4 2022 and bottomed at -$2.29 in Q1 2026.
- The 5-year median for EPS (Basic) is -$0.94 (2024), against an average of -$1.12.
- Across the five-year window, EPS (Basic) plunged 103.63% in 2023 and rose 18.75% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$0.7 in 2022, then plunged by 103.63% to -$1.43 in 2023, then gained by 18.75% to -$1.16 in 2024, then sank by 65.45% to -$1.92 in 2025, then declined by 19.37% to -$2.29 in 2026.
- Per Business Quant, the three latest RVMD EPS (Basic) figures stand at -$2.29 (Q1 2026), -$1.92 (Q4 2025), and -$1.61 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 1.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.29 |
| Dec 31, 2025 | -1.92 |
| Sep 30, 2025 | -1.61 |
| Jun 30, 2025 | -1.31 |
| Mar 31, 2025 | -1.13 |
| Dec 31, 2024 | -1.16 |
| Sep 30, 2024 | -0.94 |
| Jun 30, 2024 | -0.81 |
| Mar 31, 2024 | -0.70 |
| Dec 31, 2023 | -1.43 |
| Sep 30, 2023 | -0.99 |
| Jun 30, 2023 | -0.92 |
| Mar 31, 2023 | -0.72 |
| Dec 31, 2022 | -0.70 |
| Sep 30, 2022 | -0.87 |
| Jun 30, 2022 | -0.82 |
| Mar 31, 2022 | -0.78 |
| Dec 31, 2021 | -0.72 |
| Sep 30, 2021 | -0.72 |
| Jun 30, 2021 | -0.60 |